Soluble Transferrin Receptor (sTfR) and the sTfR / Log-Ferritin (Thomas) Index in the Heavily Trained Endurance-Athlete Iron Workup: Why Ferritin-Plus-CRP Is Not Enough When Chronic Training-Load Inflammation Sits Above the Reference, the Tissue-Iron-Demand Signal That the Acute-Phase Panel Cannot Confound, and the SOAP Structure That Carries the Index Into the Coordinated Iron-Deficiency Decision

A 26-year-old competitive triathlete presents to the sports RD at the end of a 20-week Ironman build. Base ferritin has fluctuated between 55 and 75 ng/mL across the season on quarterly draws. hs-CRP sits at 4.8 mg/L on today's panel and has carried a 3-to-6 mg/L chronic signal across every draw of the build, read by primary care as "mild inflammation, endurance training normal, no action required." Hemoglobin returned at 13.4 g/dL and MCV at 86 fL — both within reference. The primary care note from last month reads "iron status normal, no anemia, continue current training and nutrition." Power at threshold has dropped from 285W to 265W across the final 8-week training block. Submaximal heart rate at race-pace effort has climbed 7 bpm. HRV has flattened. The athlete is sleeping well, eating a documented 3,200 kcal per day on a mixed omnivorous diet, and the strength coach has ruled out overtraining syndrome on load-management review.

The primary care read is defensible against the markers that were drawn. The problem is that the markers that were drawn cannot see the iron-deficient erythropoiesis the clinical presentation is actually pointing at. Ferritin is a positive acute-phase reactant. In the chronically inflamed endurance athlete whose hs-CRP sits at 4 to 6 mg/L for twenty weeks running, the circulating ferritin concentration is inflated above what the actual bone-marrow iron stores would predict. A ferritin of 60 ng/mL in a non-inflamed athlete is a reassuring read. A ferritin of 60 ng/mL in an athlete carrying a chronic hs-CRP of 5 mg/L is a confounded read that may be masking a true functional iron deficit at the erythroid-precursor level. The marker that resolves the ambiguity is the soluble transferrin receptor (sTfR), and the interpretive instrument that pairs it against the storage-pool read is the Thomas index — sTfR divided by log(ferritin).

This is the sTfR and Thomas index interpretation guide for the sports RD managing the heavily trained endurance athlete: what sTfR actually measures and why its biology is immune to the acute-phase-reactant confounding that distorts ferritin, why the chronic hs-CRP elevation that endurance training produces is precisely the population in which the paired ferritin-plus-CRP panel is insufficient, the Thomas index interpretive framework that separates true iron-deficient erythropoiesis from inflammation-inflated ferritin from compound presentations, the four intake presentations that should trigger the sTfR referral regardless of a within-reference ferritin, and the SOAP structure that carries the index into the iron-deficiency decision before the athlete's performance regression becomes a frank anemic presentation.

What sTfR Actually Measures

The transferrin receptor is a transmembrane glycoprotein expressed on every cell in the body that imports iron through the transferrin cycle. The erythroid precursor cells in the bone marrow — the normoblasts and reticulocytes — express the receptor at the highest density of any cell type in the body, which is a reflection of their enormous iron demand to synthesize the hemoglobin that will become the circulating red cell mass. When intracellular iron supply drops below the demand required for ongoing erythropoiesis, the cell up-regulates transferrin receptor expression at the transcriptional level through the iron-responsive-element / iron-regulatory-protein (IRE/IRP) axis. More receptors on the surface means more iron import per unit of circulating transferrin, which is the cell's compensatory response to a drop in substrate.

A fraction of the full transmembrane receptor is proteolytically cleaved from the cell surface and shed into the circulation as the soluble transferrin receptor. The circulating sTfR concentration tracks very tightly with total body transferrin-receptor expression, and total body expression is dominated by the erythroid-precursor contribution. The practical consequence for the sports RD is that sTfR is a direct, quantitative read on tissue iron demand at the erythroid-precursor level. When the bone marrow is iron-sufficient, sTfR sits in a stable reference range (typically 2.2 to 5.0 mg/L on most immunoassay platforms — note that reference ranges are assay-specific and the sports RD must confirm the reporting lab's reference against the instrument). When erythroid iron demand exceeds supply, sTfR rises before the hemoglobin, MCV, or clinical anemic presentation appears.

The property that makes sTfR a distinct instrument from ferritin is the regulatory biology that governs its circulating concentration. sTfR is neither a positive nor a negative acute-phase reactant. The inflammatory cytokine cascade — IL-6, TNF-alpha, IL-1 — that drives ferritin up and prealbumin down does not meaningfully shift sTfR. An athlete running a chronic hs-CRP of 5 mg/L for twenty weeks has an sTfR that still reads what the actual erythroid iron-demand is reading. The signal the ferritin-plus-CRP panel is attempting to triangulate — "is this ferritin inflation-inflated or is it genuinely full stores?" — is a signal the sTfR reads directly without the triangulation step.

Why the Chronic Training-Load Inflammation Is the Exact Gap

The endurance athlete carrying a chronic hs-CRP in the 3-to-6 mg/L range through a 16-to-24-week build is not pathological. The signal is the integrated inflammatory consequence of repeated high-volume training stimulus, muscle microdamage, oxidative stress, and the sustained cortisol-driven stress response that heavy aerobic load produces. The signal does not require medical treatment, but it does change the interpretive calculus of every acute-phase-reactant marker drawn against it. Ferritin is the marker that lands most consequentially in the sports-nutrition workflow, and the chronic-inflammation inflation is the exact confounder that the ferritin-plus-CRP paired read is trying to catch.

The paired ferritin-plus-CRP discipline — "if CRP is elevated, discount the ferritin read" — is the right discipline for the acute inflammatory event (recent illness, injury, periodontal infection, acute training-load spike). It is a less useful discipline for the chronic sub-clinical inflammatory signal that the heavily trained endurance athlete carries continuously. "Discount the ferritin because CRP is elevated" leaves the sports RD without a defensible numeric read on the storage pool at any point in the twenty-week build, which collapses into "defer the iron workup until the off-season," which is precisely the window in which the athlete does not need the workup. The marker that sidesteps the whole triangulation problem is sTfR, and the interpretive index that combines the two reads into a single clinically useful number is the Thomas index.

The Thomas Index Interpretive Framework

The Thomas index is defined as sTfR (mg/L) divided by log10(ferritin, ng/mL). The construct combines the tissue-demand signal (sTfR, which rises as iron-deficient erythropoiesis develops) with the inverse-log of the storage-pool signal (ferritin, which falls as stores deplete), in a way that produces a single scalar that scales monotonically with the severity of the iron deficit while being substantially less sensitive to inflammation-driven ferritin inflation than ferritin alone.

The clinically useful cut-offs — again, with the assay-dependence caveat the sports RD must confirm against the specific reporting lab — generally fall as follows:

Thomas index below 1. No evidence of iron-deficient erythropoiesis. Storage pool and tissue demand are in balance. The read closes the iron-deficiency differential and the workup moves on to the next differential on the open chart (B12, folate, hormonal, overtraining syndrome).

Thomas index between 1 and 2. Iron-deficient erythropoiesis in progress. The storage pool may be depleted (true iron deficiency) or the inflammatory block on iron utilization may be the dominant mechanism (functional iron deficiency against adequate stores). The paired hepcidin draw, if available, resolves the two mechanisms — elevated hepcidin flags the inflammatory block, suppressed hepcidin flags the storage-depletion mechanism. The intervention branches accordingly. If true depletion, the alternate-day oral iron trial against the Stoffel hepcidin kinetics opens. If functional block, the intervention targets the inflammatory source (training-load adjustment, sleep, non-training stressor audit) first and the iron redraws in 8 weeks against the inflammatory recovery.

Thomas index above 2. Frank iron-deficient erythropoiesis with imminent or evolving anemia. The intervention is time-sensitive. The oral iron trial opens immediately, the hemoglobin and reticulocyte trajectory are the follow-up markers at 4 and 8 weeks, and the IV iron referral is on the chart as the fallback if oral supplementation fails to move the markers.

Thomas index below 1 against an elevated hs-CRP and a within-reference ferritin. The reassuring configuration. The ferritin inflation that would otherwise prompt an inappropriate hemochromatosis workup is correctly interpretable as inflammation-driven inflation against adequate stores. The sports RD closes the iron differential with confidence that the elevated ferritin is not a storage-overload presentation.

Thomas index between 1 and 2 against a within-reference ferritin. The configuration the ferritin-only read cannot see. The athlete appears iron-sufficient on the storage marker and is actually iron-deficient at the erythroid-precursor level. The Thomas index catches this presentation and the sports RD opens the iron-deficiency chart on an athlete who would otherwise have been dismissed as "iron normal, continue current protocol."

The Four Intake Presentations That Trigger the sTfR Referral

Any endurance athlete in the final 8 to 16 weeks of a competition build with a chronic hs-CRP in the 3-to-6 mg/L range and a ferritin that reads within reference but has not been corroborated against a tissue-demand signal. The chronic-training-inflammation configuration is the signature pattern in which the solo ferritin read is most likely to miss a developing iron deficit. The sTfR plus Thomas index is the correction.

Any endurance athlete with a performance regression that cannot be explained by training load, sleep, HRV, or recovery variables, in whom the ferritin and hemoglobin have returned within reference on a prior panel. The regression itself is the trigger. "Within-reference iron" on the storage marker is not an exclusion criterion when the tissue-demand marker has not been drawn.

Any female endurance athlete with a menstrual-cycle disruption or a known heavy-flow menstrual history in whom ferritin reads within reference against a chronic hs-CRP elevation. The compound-mechanism risk — monthly iron losses layered on chronic-training-inflammation ferritin inflation — is the exact configuration that produces a Thomas index between 1 and 2 against a reassuring-looking ferritin. The sports RD who runs the sTfR here catches the deficit the solo ferritin misses.

Any athlete transitioning from a plant-forward or vegan dietary pattern into a high-volume endurance block. The lower bioavailability of non-heme iron, combined with the elevated iron demand of the training stimulus, compounds the risk. The baseline sTfR plus Thomas index at the transition is the defensible monitoring entry point.

The SOAP Documentation

My structure on the presenting vignette reads: "Twenty-six-year-old male competitive triathlete, 20-week Ironman build, presents with 8-week performance regression (threshold power 285W to 265W), 7-bpm submaximal heart rate elevation at race-pace effort, flat HRV trend, no training-load or sleep explanation on strength-coach load-management review. Primary care panel from four weeks ago returned ferritin 62 ng/mL, hs-CRP 4.8 mg/L, hemoglobin 13.4 g/dL, MCV 86 fL — read by primary care as 'iron status normal, mild chronic inflammation consistent with endurance training, continue current training.' The within-reference ferritin is interpretable against the chronic hs-CRP elevation only via a paired tissue-demand marker, which was not drawn. Draws ordered today: sTfR, repeat ferritin, repeat hs-CRP, reticulocyte count, reticulocyte hemoglobin content (CHr) if the reporting lab offers it, TSAT, hepcidin if the reporting panel offers it. Thomas index to be calculated on return. Twenty-four-hour recall across three training days documents iron intake at 11 mg/day against the elevated-demand estimate of 18 to 20 mg/day for a male endurance athlete at this training volume, with 70 percent of the iron intake from non-heme sources, no vitamin-C co-ingestion pattern at main meals, and a frequent coffee-with-meals pattern that further suppresses non-heme bioavailability. Working differential: iron-deficient erythropoiesis against inflammation-inflated ferritin in a chronically-trained endurance athlete. Plan: sTfR panel returning in 48 to 72 hours; Thomas index to be calculated and documented against the ferritin draw; if index is 1 to 2, open the oral-iron trial on alternate-day dosing against Stoffel kinetics; if index is above 2, consider IV iron referral given the proximity to the competition window; dietary intervention opens today independent of the lab return — iron-rich food scheduling with vitamin-C co-ingestion, decoupling of coffee and tea from main meals, protein-source rotation to increase heme-iron contribution; strength coach and primary care looped on the paired-marker read and the training-load context; 4-week reticulocyte and 8-week ferritin/sTfR/Thomas-index redraw scheduled."

The assessment line names the pattern as "iron-deficient erythropoiesis against inflammation-inflated ferritin in a chronically-trained endurance athlete" rather than "iron status normal." The plan line specifies the Thomas index as the empirical instrument that drives the intervention branch. The oral-vs-IV iron decision is anchored to a defensible, documented numeric read rather than to a clinical hunch.

The Follow-Up Cadence

Reticulocyte count and reticulocyte hemoglobin content (CHr) at 4 weeks post-intervention. The reticulocyte trajectory is the earliest clinically useful indicator that the oral iron trial is restoring erythropoiesis. CHr specifically is a sensitive marker of the iron supplied to the newly-produced reticulocyte and tracks the intervention on the shortest timescale.

Repeat sTfR, ferritin, and Thomas index at 8 weeks post-intervention. The expected trajectory is sTfR falling (tissue demand recovering), ferritin rising (storage pool refilling), and Thomas index moving back below 1. If the index has not moved despite documented adherence, the differential expands — occult GI blood loss, celiac disease interfering with iron absorption, parasitic infection in the relevant geographic context, atrophic gastritis — and the primary care referral opens with the paired-marker trajectory as the handed documentation.

Thomas index monitoring at the end-of-season off-build timepoint. The chronic inflammatory signal drops when the training load drops, and the ferritin that was inflation-inflated during the build will return to its true storage-pool reading. The off-build Thomas index is the cleanest annual read on the athlete's genuine iron-storage status and anchors the next build's baseline.

Where Calsanova Fits

The sTfR and Thomas index workflow depends on the intake carrying the training-load, menstrual-cycle, and dietary-recall data at the same visit as the lab panel, the interpretive framework that calculates the Thomas index from the paired sTfR-ferritin values and holds the inflammation-confounded ferritin against the direct tissue-demand marker, the SOAP template that pre-populates the iron-deficient-erythropoiesis differential against the paired-marker read, the 4-week reticulocyte and 8-week paired-panel follow-up scheduling that catches the intervention trajectory on time, and the longitudinal end-of-season baseline draw that anchors each new build's monitoring plan. Calsanova's clinical intake carries the training-load and dietary-recall capture at the initial visit, the paired sTfR-ferritin interpretive framework with automated Thomas index calculation and assay-reference flagging built into the lab-integration module, the SOAP template that pre-populates the iron-deficient-erythropoiesis-versus-inflammation-inflated-ferritin differential against the paired-marker read, the automated follow-up scheduling that catches the 4-week reticulocyte and 8-week paired-panel windows, and the longitudinal-trajectory view that surfaces the leading-indicator signal across seasons before the frank anemic presentation forces the diagnosis.

Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the sTfR + Thomas index workup runs automatically with the training-load and dietary-recall capture, the inflammation-confounded ferritin guardrail, the SOAP template pre-populated against the paired-marker read, and the automated follow-up scheduling that confirms the intervention is moving the markers.